Taro Pharmaceuticals: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Taro Pharmaceuticals''' is a multinational | == Taro Pharmaceuticals == | ||
[[File:Taro_Pharmaceuticals_logo.svg|thumb|right|150px|Taro Pharmaceuticals logo]] | |||
'''Taro Pharmaceuticals''' is a multinational pharmaceutical company that specializes in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products. The company is known for its focus on dermatological products, topical corticosteroids, and generic medications. | |||
== History == | == History == | ||
Taro Pharmaceuticals was founded in 1950 in [[Haifa]], [[Israel]]. The company initially focused on the production of [[antibiotics]] and other essential medications. Over the years, Taro expanded its operations and product lines, establishing a significant presence in the [[United States]], [[Canada]], and other international markets. | |||
== Products == | == Products == | ||
Taro Pharmaceuticals offers a | Taro Pharmaceuticals offers a wide range of products, including: | ||
* '''Dermatological Products''': Taro is renowned for its dermatological products, which include treatments for [[psoriasis]], [[eczema]], and other skin conditions. | |||
* '''Topical Corticosteroids''': The company produces various topical corticosteroids used to treat inflammatory skin conditions. | |||
* '''Generic Medications''': Taro manufactures a variety of generic medications across different therapeutic categories. | |||
== Research and Development == | == Research and Development == | ||
Taro Pharmaceuticals | Taro Pharmaceuticals invests significantly in [[research and development]] to innovate and improve its product offerings. The company's R&D efforts are focused on developing new formulations and delivery systems for existing medications, as well as creating new therapeutic options. | ||
== Global Presence == | == Global Presence == | ||
Taro Pharmaceuticals | Taro Pharmaceuticals operates manufacturing facilities in [[Israel]], [[Canada]], and the [[United States]]. The company markets its products in over 25 countries, with a strong presence in North America and Europe. | ||
== Corporate Structure == | |||
Taro Pharmaceuticals is a publicly traded company, with its shares listed on the [[New York Stock Exchange]] under the ticker symbol TARO. The company is majority-owned by [[Sun Pharmaceutical Industries]], one of the largest pharmaceutical companies in [[India]]. | |||
== | == Related Pages == | ||
* [[Sun Pharmaceutical Industries]] | |||
* [[Generic drug]] | |||
* [[Dermatology]] | |||
* [[Pharmaceutical industry]] | * [[Pharmaceutical industry]] | ||
{{Pharmaceutical companies}} | |||
[[Category:Pharmaceutical companies of Israel]] | |||
[[Category:Companies listed on the New York Stock Exchange]] | |||
[[Category:Generic drug manufacturers]] | |||
Latest revision as of 16:30, 16 February 2025
Taro Pharmaceuticals[edit]

Taro Pharmaceuticals is a multinational pharmaceutical company that specializes in the development, manufacturing, and marketing of prescription and over-the-counter pharmaceutical products. The company is known for its focus on dermatological products, topical corticosteroids, and generic medications.
History[edit]
Taro Pharmaceuticals was founded in 1950 in Haifa, Israel. The company initially focused on the production of antibiotics and other essential medications. Over the years, Taro expanded its operations and product lines, establishing a significant presence in the United States, Canada, and other international markets.
Products[edit]
Taro Pharmaceuticals offers a wide range of products, including:
- Dermatological Products: Taro is renowned for its dermatological products, which include treatments for psoriasis, eczema, and other skin conditions.
- Topical Corticosteroids: The company produces various topical corticosteroids used to treat inflammatory skin conditions.
- Generic Medications: Taro manufactures a variety of generic medications across different therapeutic categories.
Research and Development[edit]
Taro Pharmaceuticals invests significantly in research and development to innovate and improve its product offerings. The company's R&D efforts are focused on developing new formulations and delivery systems for existing medications, as well as creating new therapeutic options.
Global Presence[edit]
Taro Pharmaceuticals operates manufacturing facilities in Israel, Canada, and the United States. The company markets its products in over 25 countries, with a strong presence in North America and Europe.
Corporate Structure[edit]
Taro Pharmaceuticals is a publicly traded company, with its shares listed on the New York Stock Exchange under the ticker symbol TARO. The company is majority-owned by Sun Pharmaceutical Industries, one of the largest pharmaceutical companies in India.
Related Pages[edit]
| Pharmaceutical companies | ||||||
|---|---|---|---|---|---|---|
|